The US biotech and life sciences industry has a long and proud history of driving medical innovations that have improved healthcare outcomes across a wide range of diseases and the overall quality of life for people worldwide.
For too long, however, the industry’s narrative has been dominated and defined by partisans with a specific agenda who do not always provide the broader public with the context needed to be fully informed on key issues.
Despite the societal benefit of the innovative technologies and therapeutics coming out of biotech, the broader discussion and debate in the news media and across the political… Read more »
UNDERWRITERS AND PARTNERS
